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Meeting Summary
The  annual  Society  of  General  Physiologists  (SGP) 
symposium  has  a  six-decade  legacy  as  the  premier 
and innovative international meeting for physiologists, 
cell  biologists,  and  biophysicists.  During  September 
7–11th, 2011, more than 130 scientists participated in the 
65th SGP symposium entitled “Mitochondrial Physiology 
and Medicine” at Woods Hole, MA. In a survey dis-
tributed  at  the  end  of  the  conference,  participants 
ranked the overall science and quality of discussions 
very highly (average of 9.5 out of 10), with multiple 
respondents  noting  the  highly  collegial  atmosphere, 
emphasis  on  unpublished  research,  and  opportunity 
for younger scientists to interact with leaders in the field.
Recent  groundbreaking  discoveries  demonstrating 
the pivotal role of mitochondria in human physiology 
and  disease  have  repositioned  mitochondria  to  the   
center stage of biomedical research. Mitochondria serve 
as gatekeepers between cell survival and death, as well 
as regulate proper cell signaling, energy metabolism, 
redox balance, and ion homeostasis. Mitochondrial dys-
function is associated with numerous acute and chronic 
human diseases, including heart failure, ischemia-reper-
fusion injury, atherosclerosis, cardiomyopathy, stroke, 
neurodegeneration, diabetes, obesity, cancer, rare dis-
eases, and aging. Clearly, the SGP’s selection of this year’s 
topic on mitochondrial physiology and disease was timely 
and fitting.
The meeting was organized by Shey-Shing Sheu along 
with a committee consisting of recognized leaders in 
mitochondrial  research,  including  Robert  Balaban, 
Paolo  Bernardi,  Robert  Dirksen,  Roberta  Gottlieb, 
Gyorgy Hajnóczky, and Brian O’Rourke. The program 
included two keynote speakers, both members of National 
Academy of Sciences: David Clapham, who spoke on 
“Mitochondrial Ca
2+ Entry Pathways,” and Douglas Wallace, 
whose  talk  was  entitled  “A  Bioenergetic  Etiology  for 
Complex Diseases: Interaction between Mitochondrial 
Genetics and the Epigenome.” The themes for the five ses-
sions were: (1) mitochondrial morphology and dynamics; 
(2) system biology of mitochondria; (3) mitochondrial 
ion channels and transporters; (4) mitochondrial signal-
ing, Ca
2+, and reactive oxygen species (ROS); and (5) mito-
chondria in cell death and disease (for the complete 
program, see http://www.sgpweb.org/symposium2011 
.html). These topics represent an integration of mito-
chondrial physiology and medicine from molecular 
to human levels, with a special emphasis on the role of 
mitochondria as therapeutic targets in human disease. 
Speakers included not only the established leaders in 
the mitochondrial research field, but also, several “ris-
ing stars” and junior investigators were invited to present 
short talks. Two special sessions on “controversies and 
breaking news” were added to the program by choosing 
presenters whose abstract contained controversial and 
exciting unpublished results. A total of 71 posters were 
presented in two poster sessions.
On the evening of September 7th, David Clapham 
delivered the first keynote address. Clapham’s group 
made a major contribution to the mitochondrial Ca
2+ 
transport  field  by  recording  the  Ca
2+  current  of  the 
mitochondrial inner membrane Ca
2+ uniporter (MCU) 
with the patch-clamp technique applied to mitoplasts 
generated from COS-7 cells. The recording of single-
channel activity unequivocally established that MCU is 
an  ion  channel  (MiCa).  The  results  established  that 
MiCa, which is responsible for 80% of the total inner 
membrane current, is a highly Ca
2+-selective ion chan-
nel with extremely high Ca
2+ affinity (2 nM), enabling 
high Ca
2+ selectivity despite relatively low cytosolic Ca
2+ 
concentrations (100 nM) (Kirichok et al., 2004). The 
MiCa is permeable to Sr
2+ but not K
+ and is not inacti-
vated by internal Ca
2+. The extremely high Ca
2+ affinity 
seems at odds with the common belief that MCU has a 
relatively  low  Ca
2+  affinity  Ca
2+  transporter.  Clapham 
also presented his group’s discovery of Letm1 (leucine 
zipper EF hand–containing transmembrane protein 1) 
through a genome-wide RNA interference screen as a 
mitochondrial  Ca
2+/H
+  antiporter  of  the  inner  mito-
chondrial membrane (Jiang et al., 2009). Letm1 pro-
teins  are  evolutionarily  conserved  homomeric  inner 
membrane proteins, but their function was not previ-
ously established. Ca
2+ uptake through Letm1 is more 
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y564 Meeting summary
junctions stabilize the position of some mitochondria, 
the  mitochondrial  population  as  a  whole  undergoes 
permanent remodeling that involves movements and 
fusion–fission. Mitochondrial dynamics is anticipated 
to  attract  growing  attention  because  mutations  of 
some  of  the  key  proteins  are  associated  with  and 
likely to contribute to a variety of human diseases. Fi-
nally, the integration of localized and global Ca
2+ sig-
naling  in  regulating  cell  function  is  a  major  topic  in 
mitochondrial research. Brian O’Rourke indicated the 
necessity  of  the  application  of  theoretical  modeling 
for evaluating and assimilating experimental data in 
the field. He used an example that connects various 
ionic  circuits  (K
+,  Ca
2+,  Na
+,  and  H
+)  in  the  plasma 
membrane, ER/SR, and mitochondria and predicts, on 
a  beat-to-beat  basis,  how  these  parameters  work  to-
gether  to  orchestrate  cellular  energy,  Ca
2+,  and  ROS 
metabolism in cardiac muscle. This integration of knowl-
edge will be extremely important in our understanding 
of  cardiac  protection,  injury,  apoptosis,  and  arrhyth-
mias. Finally, because more and more signaling proteins 
have  been  identified  in  the  mitochondria,  the  post-
translational modifications of mitochondrial proteins 
will become an increasingly hot topic. Robert Dirksen 
concurred with O’Rourke, emphasizing the need for 
integrative  physiology  in  investigating  normal  mito-
chondrial  function  and  disease  affecting  it,  and  how 
strongly future medicine will depend on the translation 
of basic mitochondrial biology to integrative human 
physiology. Robert Balaban echoed the views of O’Rourke 
and  Dirksen,  and  emphasized  the  importance  of  a   
systems biology approach in mitochondrial research, 
noting that in his opinion, the mitochondrion affords 
one  of  the  best  opportunities  in  all  of  cell  biology   
for developing a complete understanding of a how a 
complex,  multimolecular  organelle  functions.  Paolo 
Bernardi reminded us that all the new discoveries 
need  to  fit  the  basic  principles  of  thermodynamics,   
such  as  Peter  Mitchell’s  chemiosmotic  theory,  and 
urged the students and junior investigators to study the 
history  of  major  mitochondrial  research  discoveries. 
Strong courses in mitochondrial biology are essential 
for  the  education  of  the  next  generation  of  mito-
chondriacs. Orian Shirihai passionately elaborated on 
this point.
The  content  of  the  roundtable  discussion  on  the 
opening night of the symposium was both stimulating 
and remarkably prophetic as it served to foreshadow 
several central themes that were revisited throughout 
the remainder of the week. These themes included the 
molecular identification of mitochondrial ion channels 
and  transporters,  mechanisms  controlling  mitochon-
drial dynamics, the power of mitochondrial proteomics, 
quantitative modeling of mitochondrial function, and 
the central role mitochondria play in cell survival, death, 
and disease.
energetically conserving than other Ca
2+ uptake mecha-
nisms because one Ca
2+ uptake is coupled with one 
H
+ extrusion. Knockdown of Letm1 abolished the initial 
fast mitochondrial Ca
2+ uptake by histamine. Letm1 was 
previously found to be related to Wolf-Hirshhorn syn-
drome, characterized by neurological disorders such 
as mental retardation and seizure. One controversial 
issue is that Letm1 has been characterized as a K
+/H
+ 
exchanger. Published results show that the K
+/H
+ ex-
changer  nigericin  reverses  all  mitochondrial  defects 
caused by the absence of Letm1. This raised the debate 
of  whether  the  Letm1-associated  Ca
2+  changes  are 
secondary to the changes in K
+.
Clapham’s talk was followed by a roundtable discus-
sion  on  the  future  of  mitochondrial  physiology  and 
medicine. Douglas Wallace opened the discussion with a 
vision of complex diseases seen through the lens of mito-
chondria and their role in bioenergetics. The high rate 
of mitochondrial DNA (mtDNA) mutation (1,000-fold 
higher than that of nuclear DNA [nDNA]) and its 
relatively high susceptibility to ROS generated by the 
respiratory chain place them at the epicenter of com-
plex diseases. Wallace stated that this realization argues 
for a shift in focus from nDNA to mtDNA and the 
epigenome.  He  envisioned  that  a  multidisciplinary 
approach to elucidate mtDNA genetic changes and 
epigenome fluctuations will be critical in our under-
standing of the etiology and search for cures of complex 
human diseases. Roberta Gottlieb agreed with Wallace 
that bioenergetics is an arbiter for cell life and death. 
She noted that cellular energy homeostasis in all tissues 
is critically dependent on mitochondrial quality control, 
which  is  regulated  by  a  balance  between  ongoing  bio-
genesis and autophagic destruction. In addition, mito-
chondrial quality control depends on a delicate, dynamic 
balance between mitochondrial fission and fusion. Thus, 
elucidation of molecular and cellular mechanisms of 
mitochondrial  biogenesis  and  autophagy/mitophagy   
is a burning issue in mitochondrial research. Gyorgy 
Hajnóczky first drew attention to recent identification 
of major mitochondrial Ca
2+ transport proteins, includ-
ing Letm1, NCLX, MICU1, and MCU. He envisioned 
that these breakthrough discoveries will lead the field of 
mitochondrial Ca
2+ signaling to explosive growth because 
molecular and structural manipulations are now readily 
accessible. Specifically, these manipulations will aid in 
the dissection of both the molecular mechanisms and 
physiological relevance of mitochondrial Ca
2+ uptake. He 
then pointed out that the study of endoplasmic reticulum 
(ER)/sarcoplasmic  reticulum  (SR)-mitochondrial  junc-
tions that are central to Ca
2+ delivery to the mitochon-
dria has also been undergoing tremendous progress. 
The ER/SR-mitochondrial junctions are also the sub-
ject  of  immense  interest  because  of  their  important 
roles  in  phospholipid  synthesis  and  interorganellar 
protein  transfer.  Although  the  ER/SR-mitochondrial   Sheu et al. 565
exciting and challenging open questions in this field   
is  to  nail  down  the  precise  molecular  identity  of  the 
mPTP.  Kathleen  Kinnally  summarized  evidence  that 
Bax/Bak oligomerize in the outer mitochondrial mem-
brane to form the mitochondrial apoptosis-induced chan-
nel (MAC), an alternate death channel through which 
cytochrome c can be released. Kinnally proposed that 
the MAC channel underlies the so-called “bystander ef-
fect,” whereby cytochrome c released in one cell triggers 
apoptosis in neighboring cells (Peixoto et al., 2011).
Mitochondrial dynamics: Motility, fusion, and fission
Another major theme of the symposium was mitochon-
drial dynamics, the molecular mechanisms that control 
mitochondrial motility, fission, and fusion as presented 
by Gyorgy Hajnoczky, Orian Shirihai, Yisang Yoon, and 
Roberta Gottlieb.
Published work has identified several protein fusion 
factors (Mfn1, Mfn2, Opa1) and fission factors (DLP1/
Drp1, Mff, Fis1). Drp1, for example, is a normally soluble 
dynamin-related  protein  proposed  to  act  in  concert 
with ER extensions to “cinch” mitochondria in prepara-
tion for fission (Friedman et al., 2011). Evidence was 
provided demonstrating that outer and interior mem-
branes of adjacent mitochondria in many tissues in-
cluding muscle are dynamically interconnected, allowing 
intermitochondrial transfer of proteins in both com-
partments, with full fusion at one end of this connectiv-
ity. As shown by Shirihai, often one of the daughter 
mitochondria of a fission event becomes depolarized 
and subsequently undergoes autophagy (“mitophagy”). 
This and observations by other speakers suggest the 
important hypothesis that mitophagy functions as a qual-
ity control system in which compromised mitochondrial 
proteins (e.g., oxidized by ROS) are first segregated by 
fission or by whole mitochondrion targeting, and then 
removed by mitophagy (Gustafsson and Gottlieb, 2009; 
Gottlieb and Carreira, 2010). Seen in the light of this 
hypothesis, many aspects of mitophagy are brought into 
sharper focus, such as the harmful reduction of mitoph-
agy by high fat diets (Las et al., 2011), and the potential 
therapeutic utility of increased mitophagy in ischemic 
preconditioning (Huang et al., 2011).
Mitochondrial proteomics
Based on work presented at the symposium, mitochon-
drial proteomics clearly represents another important 
and rapidly emerging area in mitochondrial research. 
During the meeting, Vamsi Mootha discussed how new 
insights into mitochondrial function and disease can be 
mined using MitoCarta (http://www.broadinstitute.org/
pubs/MitoCarta/index.html), a comprehensive inventory 
of more than 1,000 mouse and human genes encoding 
proteins revealed by mass spectrometry and found to be 
localized to mitochondrial across a wide range of tissues 
(Pagliarini et al., 2008). For example, MitoCarta was used 
Molecular identities of mitochondrial channels  
and transporters
A major theme of the conference focused on recent 
advances in the molecular identification of mitochondrial 
transporters.  After  the  biophysical  characterization  of 
the mitochondrial Ca
2+ uniporter channel by Clapham 
and  colleagues  (Kirichok  et  al.,  2004),  two  groups 
represented at the symposium identified the molecular 
mechanism. Building on their previous proteomic analysis 
(the “MitoCarta”) (Pagliarini et al., 2008), Vamsi Mootha 
and colleagues used comparative genomics, RNAi screen-
ing, and measurement of mitochondrial calcium fluxes 
to identify the MCU (Baughman et al., 2011) and MICU1 
(Perocchi et al., 2010), a novel protein with two EF hands 
that functions as the Ca
2+ sensor for MCU. Indepen-
dently, Rosario Rizzuto and colleagues used MitoCarta 
to identify MCU in silico, and used several physiological 
assays (including siRNA interference and overexpres-
sion in HeLa cells; single-channel recordings in lipid 
bilayers with mutagenesis) to validate the essential role   
of this protein in mediating mitochondrial Ca
2+ uptake 
(De Stefani et al., 2011).
Other identifications reported in the meeting included 
David Clapham’s characterization of LETM1 as a mito-
chondrial Ca
2+/H
+ antiporter of the inner mitochon-
drial membrane (Jiang et al., 2009); Brian O’Rourke’s 
identification of Kir1.1 (ROMK) as “MitoK,” the ATP- 
and  glibenclamide-sensitive  K  channel  involved  in 
ischemic preconditioning and reperfusion protection; 
and Yiuriy Kirichok’s identification of the uncoupler 
protein UCP1 as a proton/fatty acid transporter.
A major unresolved issue in mitochondrial physiology 
is the elucidation of the complete molecular identity of 
the mitochondrial permeability transition pore (mPTP) 
(Di Lisa and Bernardi, 2006; Halestrap, 2006; Ricchelli 
et al., 2011). The mPTP is a voltage-dependent high 
conductance (1,200 pS) channel located in the inner 
mitochondrial membrane. When the channel is open, 
it allows passive movement of solutes with molecular 
masses of up to 1.5 kD. Paolo Bernardi gave an inspir-
ing historical overview of mPTP research and the impor-
tance of this mechanism in physiology (e.g., as a rapid Ca
2+ 
release channel), cell death (e.g., ischemia-reperfusion 
injury),  and  disease  (e.g.,  congenital  muscular  dystro-
phy). In spite of the identification of mPTP function 
over 30 years ago (Hunter and Haworth, 1979a,b), the 
molecular identity of the mPTP remains enigmatic. It 
has  been  hypothesized  that  mPTP  is  a  multiprotein 
complex, with ANT, cyclophilin-d, and phosphate car-
rier as the key components, and mitochondrial creatine 
kinase, hexokinase, voltage-dependent anion channel, 
and Bcl-2 family members serving important regulatory 
functions. However, Jeffrey Molkentin noted that re-
sults from knockout mice have so far supported a role 
for cyclophilin-d, but not VDAC or ANT, as an essen-
tial component of the mPTP. Clearly, one of the most 566 Meeting summary
cell death required for proper embryonic development 
and tissue homoeostasis. Atan Gross presented his re-
cent discovery of a 33-kD protein MTCH2/MIMP, a 
member  of  the  mitochondrial  carrier  protein  family, 
which forms a complex with activated tBID to cause per-
meabilization  of  the  mitochondrial  outer  membrane 
that triggers cell death. He also showed that MTCH2/
MIMP deletion in the liver leads to a profound reduc-
tion  in  hepatic  levels  of  fatty  acids,  consistent  with 
MTCH2/MIMP regulating mitochondrial fatty acid me-
tabolism. These findings raise the intriguing possibility 
of cross talk signaling between mitochondrial energy 
metabolism and tBID receptor–like protein during apop-
tosis. The crux of Kevin Foskett’s presentation is the 
idea that mitochondrial Ca
2+ uptake during constitutive 
InsP3R Ca
2+ release from the ER is a fundamental cellu-
lar process required for efficient mitochondrial respira-
tion and maintenance of normal cellular bioenergetics. 
Any disturbances of this “privileged” inter-organelle Ca
2+ 
transport  would  contribute  to  cellular  energetic  dys-
function, injury, and disease. As discussed above, an-
other key player in dictating cell survival and death is 
the mPTP. Although transient openings of the mPTP is 
proposed to serve as a physiologically important rapid 
mitochondrial Ca
2+ efflux mechanism, persistent mPTP 
activation results in mitochondrial membrane potential 
depolarization, cytochrome c release, and cell death. 
Indeed, mPTP activation is linked to cell damage/death 
in cardiac ischemia-reperfusion injury and muscle pa-
thology observed in collagen VI diseases, and these ef-
fects  are  greatly  diminished  by  inhibition  of  mPTP 
activity. The successful translation of these fundamental 
findings to the development of new and effective thera-
pies in humans remains a major frontier in mitochon-
drial research.
Concluding session
The symposium culminated on the evening of Septem-
ber  10th  with  the  second  keynote  address  given  by 
Douglas Wallace. The title of his lecture was “A Bioener-
getic  Etiology  for  Complex  Diseases:  Interaction  be-
tween  Mitochondrial  Genetics  and  the  Epigenome.” 
Wallace, a pioneer in the field of human mitochondrial 
genetics for over 30 years, passionately advocated the 
importance of bioenergetic dysfunction in a wide range 
of both rare and common diseases. He described that 
traditional thinking in Western medicine is based on a 
predominately anatomical perspective of disease and a 
Mendelian perspective of genetics. However, the search 
for common disease variants in the nDNA has not been 
fruitful because the environment plays a major role in 
the etiology of common diseases. In his keynote lecture, 
Wallace provided a bioenergetic perspective on biology 
and medicine. Specifically, Wallace proposed that the 
availability  and  utilization  of  calories  (energy)  is  the 
most important factor in the environment, which clearly 
by both Mootha’s group (Bashyam, 2008; Baughman et al., 
2011) and Rosario Rizzuto and colleagues (De Stefani 
et  al.,  2011)  to  identify  novel  proteins  involved  in   
mitochondrial Ca
2+ uptake (MICU1 and MCU). Brian 
O’Rourke  discussed  work  that  combined  proteomic, 
bioinformatic, and functional analyses to demon  strate 
the presence and function of ROMK channels in the 
mitochondrial inner membrane, suggesting that these 
channels play an important role in controlling K
+ ion 
transport  into  and  out  of  the  mitochondrial  matrix,   
and  are  a  candidate  for  the  elusive  mitochondrial 
KATP channel. Finally, Peipei Ping presented an im-
pressive in scope analysis of the mouse cardiac mito-
chondrial phosphoproteome that she used to identify 
several potential regulatory pathways, protein kinases/
phosphatases, and phospho-targets that are likely to 
significantly impact mitochondrial function. Although 
these and other similar studies are already beginning to 
provide important new and unanticipated insights into 
mitochondrial biology, the current state of our under-
standing of the mitochondrial proteome is clearly only 
in its infancy.
Modeling mitochondrial function
A synthetic theme running through several of the talks, 
including those of Aon, Balaban, Bernardi, and O’Rourke, 
was the need for a systems biology approach, including 
formal  modeling,  to  many  aspects  of  mitochondrial 
function. Miguel Aon’s presentation on the role of anti-
oxidant defenses in determining mitochondrial redox 
balance ably illustrated this theme (Wei et al., 2011). 
Balaban exemplified the theme in an analysis of the 
large quantitative differences in the dynamic range (av-
erage metabolic rate vs. maximum rate) of different tis-
sues (e.g., heart and liver mitochondria) and species. 
Variation in rates of key respiratory processes are only 
partially explicable in terms of the mitochondrial pro-
teomes of the different tissues and species, and lead 
to consideration of posttranslation modifications, in 
particular,  the  phosphoproteomes.  The  future  chal-
lenge lies on integration of massive, but incomplete, 
information regarding mitochondrial metabolic signal-
ing networks with human physiology and pathology.
Mitochondrial role in cell survival, death, and disease
As  described  above,  Roberta  Gottlieb  stressed  that 
because mitochondria are key arbiters for numerous 
diseases, mitochondrial quality control provides a critical 
step in cell survival and disease prevention. Mitochon-
dria achieved this quality control by establishing a delicate 
balance  between  eliminating  damaged  and  dysfunc-
tional  mitochondria  via  autophagy  (mitophagy)  and 
generating new and healthy mitochondria via biogene-
sis,  fusion,  and  fission.  Just  like  mitochondria,  cells 
also exhibit complex quality control mechanisms. For 
example, apoptosis is a crucial process for physiological   Sheu et al. 567
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brings mitochondria to the center stage of common 
disease etiology. For living species to adapt to regional and 
seasonal diversities in calorie availability, stable changes 
in cellular energetics over many years are needed, which is 
most readily achieved by the accumulation over time of 
functional  variants  in  the  mtDNA.  The  mtDNA  has  a 
high mutation rate, and the most injurious mtDNA muta-
tions are eliminated before fertilization through a mater-
nally inherited selective system. Moreover, cyclic seasonal 
changes in gene expression are achieved by alterations   
in the epigenome, which permits coordinate expression 
of the hundreds of nDNA-encoded bioenergetic genes. 
Therefore, Wallace concluded that genetic variants that 
predispose individuals to common diseases are predomi-
nantly a result of alterations in the mtDNA and the epi-
genome, not the nDNA. It can be envisioned that the 
central role of mitochondria in controlling this “flow of 
energy” will continue to drive new seminal discoveries 
and advances in physiology and medicine.
Upcoming JGP Perspectives on mitochondrial physiology 
and medicine
The success of the Mitochondrial Physiology and Medi-
cine Symposium has inspired a future JGP Perspectives 
series that will broadly address many of the major themes 
of the 2011 SGP Symposium. For this upcoming Perspec-
tives series, a subgroup of symposium speakers selected 
and recruited by representatives from the SGP council and 
the JGP editorial board will address several current con-
troversies and breakthroughs in their respective fields.
This symposium was generously supported by the National Insti-
tutes of Health (NHLBI, NIDDK, and ORDR), Seahorse Biosci-
ence,  Photometrics,  and  Jefferson  Medical  College  Center  for 
Translational Medicine.
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